Evidence map›Paper›PMID 39200437›Full record

ArticleFoods (Basel, Switzerland)2024

Research on Using K-Means Clustering to Explore High-Risk Products with Ethylene Oxide Residues and Their Manufacturers in Taiwan.

Li-Ya Wu, Fang-Ming Liu, Wen-Chou Lin, Jing-Ting Qiu, Hsu-Yang Lin, King-Fu Lin

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Li-Ya WuFood and Drug Administration, Ministry of Health and Welfare, Taipei 115209, Taiwan.ORCID 0000-0002-9577-5671
Fang-Ming LiuFood and Drug Administration, Ministry of Health and Welfare, Taipei 115209, Taiwan.
Wen-Chou LinFood and Drug Administration, Ministry of Health and Welfare, Taipei 115209, Taiwan.
Jing-Ting QiuFood and Drug Administration, Ministry of Health and Welfare, Taipei 115209, Taiwan.
Hsu-Yang LinFood and Drug Administration, Ministry of Health and Welfare, Taipei 115209, Taiwan.
King-Fu LinFood and Drug Administration, Ministry of Health and Welfare, Taipei 115209, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the frequency of ethylene oxide (EtO) residues found in food, the health effects of EtO have become a concern. Between 2022 and 2023, 489 products were inspected using the purposive sampling method in Taiwan, and nine unqualified products were found to have been imported; subsequently, border control measures were enhanced. To ensure the safety of all imported foods, the current study used the K-means clustering method for identifying EtO residues in food. Data on finished products and raw materials with EtO residues from international public opinion bulletins were collected for analysis. After matching them with the Taiwan Food Cloud, 90 high-risk food items with EtO residues and 1388 manufacturers were screened. The Taiwan Food and Drug Administration set up border controls and grouped the manufacturers using K-means clustering in the unsupervised learning algorithm. For this study, 37 manufacturers with priority inspections and 52 high-risk finished products and raw materials with residual EtO were selected for inspection. While EtO was not detected, the study concluded the following: 1. Using international food safety alerts to strengthen border control can effectively ensure domestic food safety; 2. K-means clustering can validate the risk-based purposive sampling results to ensure food safety and reduce costs.

Indexed as

ethylene oxidefood safetyK-means clusteringunsupervised learning

Identifiers

PMID39200437
PMCPMC11354176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.